Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 77 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8679545

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  2. US 8673897

    Benzodiazepinone compounds and methods of treatment using same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  3. US 8674118

    Compounds and methods for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  4. US 8673887

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  5. US 8669258

    Treatment for gastroparesis using sepiapterin

    The Board of Regents of the University of Texas System · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  6. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  7. US 8664251

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  8. US 8664273

    Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  9. US 8663649

    Diagnosis and treatment of Trypanosoma cruzi infection and Chagas disease

    The Board of Regents of the University of Texas System · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  10. US 8658616

    Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

    University College Cardiff Consultants Limited · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  11. US 8658627

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  12. US 8658787

    Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease

    GALECTIN THERAPEUTICS, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  13. US 8658674

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  14. US 8658626

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  15. US 8653027

    Method of treatment of type-1 diabetes with humanin analogues

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  16. US 8648102

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  17. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    TAKEDA GMBH · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  18. US 8648119

    Controlled release immunomodulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  19. US 8642282

    Inhibitors of nitric oxide synthase for treatment of melanoma

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  20. US 8636988

    Composition for treatment of sunburned skin

    Doctor Essentials · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  21. US 8637560

    Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  22. US 8637013

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  23. US 8637538

    Methods for treatment of pruritis

    Trevi Therapeutics, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  24. US 8629119

    Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders

    The Board of Regents of the University of Texas System · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.